N-(1-(3-acrylamidophenylsulfonyl)piperidin-4-yl)-4-(2,4,6-trichlorobenzamido)-1H-pyrazole-3-carboxamide 2,2,2-trifluoroacetate

ID: ALA4474689

PubChem CID: 155537280

Max Phase: Preclinical

Molecular Formula: C27H24Cl3F3N6O7S

Molecular Weight: 625.92

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  C=CC(=O)Nc1cccc(S(=O)(=O)N2CCC(NC(=O)c3n[nH]cc3NC(=O)c3c(Cl)cc(Cl)cc3Cl)CC2)c1.O=C(O)C(F)(F)F

Standard InChI:  InChI=1S/C25H23Cl3N6O5S.C2HF3O2/c1-2-21(35)30-16-4-3-5-17(12-16)40(38,39)34-8-6-15(7-9-34)31-25(37)23-20(13-29-33-23)32-24(36)22-18(27)10-14(26)11-19(22)28;3-2(4,5)1(6)7/h2-5,10-13,15H,1,6-9H2,(H,29,33)(H,30,35)(H,31,37)(H,32,36);(H,6,7)

Standard InChI Key:  YNQUOCFORHXVGP-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 47 49  0  0  0  0  0  0  0  0999 V2000
   40.2243  -14.6786    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.9320  -14.2700    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.5166  -14.2700    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   40.2243  -15.4958    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   39.5144  -15.0831    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   41.6397  -14.6786    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   40.9320  -13.4528    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   36.5136  -16.3603    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   36.5177  -15.5431    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   35.8079  -15.9482    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   31.6228  -12.7119    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.4400  -12.7119    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   31.2142  -12.0042    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   31.2142  -13.4196    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.3979  -13.4168    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.9894  -14.1237    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.3981  -14.8324    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.2195  -14.8298    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.6243  -14.1223    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.0744  -12.7119    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.8486  -12.0063    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.6658  -12.0042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.9163  -11.2262    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   33.2538  -10.7476    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   32.5940  -11.2298    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.8916  -12.7119    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   33.6658  -13.4196    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   35.3002  -13.4196    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.8905  -14.1253    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.2956  -14.8309    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.1131  -14.8351    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   36.5239  -14.1275    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.1172  -13.4158    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.3362  -15.5474    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.7391  -16.2595    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.5555  -16.2629    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.9676  -15.5562    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.5573  -14.8446    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.7422  -14.8447    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.9611  -16.9724    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   39.7782  -16.9759    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.1838  -17.6853    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.1899  -16.2699    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   41.0010  -17.6888    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.9907  -12.7083    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   32.4415  -14.1188    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   29.9904  -15.5406    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  0
  1  5  1  0
  2  6  1  0
  2  7  2  0
  9  8  2  0
 10  9  2  0
 11 12  1  0
 11 13  2  0
 11 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 14  1  0
 12 21  1  0
 22 20  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  1  0
 25 21  2  0
 20 26  1  0
 20 27  2  0
 26 28  1  0
 28 29  1  0
 28 33  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
 31  9  1  0
  9 34  1  0
 34 35  2  0
 35 36  1  0
 36 37  2  0
 37 38  1  0
 38 39  2  0
 39 34  1  0
 36 40  1  0
 40 41  1  0
 41 42  1  0
 41 43  2  0
 42 44  2  0
 15 45  1  0
 19 46  1  0
 17 47  1  0
M  END

Associated Targets(Human)

CDK14 Tchem Cyclin-dependent kinase 14/Cyclin-Y (136 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 625.92Molecular Weight (Monoisotopic): 624.0516AlogP: 4.33#Rotatable Bonds: 8
Polar Surface Area: 153.36Molecular Species: NEUTRALHBA: 6HBD: 4
#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 4#RO5 Violations (Lipinski): 2
CX Acidic pKa: 10.75CX Basic pKa: 0.01CX LogP: 4.15CX LogD: 4.15
Aromatic Rings: 3Heavy Atoms: 40QED Weighted: 0.27Np Likeness Score: -1.80

References

1. Ferguson FM, Doctor ZM, Ficarro SB, Marto JA, Kim ND, Sim T, Gray NS..  (2019)  Synthesis and structure activity relationships of a series of 4-amino-1H-pyrazoles as covalent inhibitors of CDK14.,  29  (15): [PMID:31175010] [10.1016/j.bmcl.2019.05.024]

Source